[1]
Bertoncini, C.W., Hunzicker, G.A., Rodríguez, M.P., Baldo, M.N., Acevedo, M.C., Lorenzon, G., Fritz, M.C., Rosenbrock, L., Domínguez, M.C., Cembal, S. and Gossis, S. 2020. Bioequivalence study of Binap®, ibrutinib 140 mg capsules manufactured by Laboratorio Varifarma S.A., compared to the reference product Imbruvica®. Journal of Hematology. 24, 3 (Dec. 2020), 25–37.